Most pharma digitalisation projects never leave the pilot stage. AUTOMA+ 2026 is built for the ones that do. Fragmented systems, unclear ROI and weak operational integration undermine more transformation initiatives than any technology failure. The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026, taking place on 16-17 November in Zurich, Switzerland, brings together the decision-makers, technology experts and implementation specialists who are done experimenting and ready to scale.
The programme cuts through theory and focuses on what works in real industrial environments. Sessions are built around real implementation experience – decisions made, obstacles overcome and results achieved on the ground. Participants gain insights into Rubedo Life Sciences’ use of data-driven agility within a heavily regulated environment, AGILOXServices GmbH’s deployment of autonomous mobile robotics to improve manufacturing efficiency and many other cases. Moreover, a dedicated workshop led by Joachim Bär, Boehringer Ingelheim, offers hands-on perspectives on digital plant modelling and its direct impact on production efficiency and sustainability.
Beyond the agenda, AUTOMA+ creates space for the conversations that matter most. Dedicated meetings connect high-level management, technical specialists and operational experts, who share the same operational challenges – making the Congress as valuable for the relationships built as for the knowledge exchanged.
Successful digitalisation is no longer about running pilots. It is about building the organisational capability to execute at scale, sustain change and deliver results that show up on the bottom line. AUTOMA+ 2026 is where that work begins.
Secure your place at https://sh.bgs.group/4av and come ready to move from insight to action.
